Athersys stem-cell therapy for bowel disease fails in study – Reuters
|
Athersys stem–cell therapy for bowel disease fails in study
Reuters April 28 (Reuters) – Athersys Inc said its experimental stem–cell therapy for treating an inflammatory bowel disease failed to show any benefit in patients in a mid-stage trial. The trial, conducted by Athersys’s partner Pfizer Inc , did not show a … Athersys Announces Results From Phase 2 Study of MultiStem(R) Cell Therapy …Wall Street Journal |
